Paykel-backed NZ serum exporter snaps up Aussie rival

Paykel-backed NZ serum exporter snaps up Aussie rival
Acquiring CellSera adds a 'critical new serum' to the Auckland firm’s existing product range. (Photo: supplied)
Dan Brunskill
Animal serum and plasma exporter Auckland BioSciences (ABS) has purchased an Australian competitor as it seeks to become a global industry leader.The company manufactures and exports premium New Zealand-made animal-derived serum and plasma, which are key ingredients for growing cells for bio-pharmaceutical manufacturing and medical research. While it’s not a glamourous export, this serum is vital to biotech research and the production of vaccines – including some for covid-19.“While our business is operationally complex,...

More Markets

Australian company seeks A$30m for Otago gold mining
Markets

Australian company seeks A$30m for Otago gold mining

Santana Minerals wants to 'rapidly advance' a South Island gold mining project.

NZ sharemarket celebrates highest single-day rise in over five months
Markets Market close

NZ sharemarket celebrates highest single-day rise in over five months

The S&P/NZX 50 Index closed at 11,946.43, increasing 143.15 points or 1.21%.

Graham Skellern 24 Apr 2024
'Serious compliance breaches' in NZ sharemarket
Markets

'Serious compliance breaches' in NZ sharemarket

Seven matters were referred to the NZ Markets Disciplinary Tribunal last year.

Murray Jones 24 Apr 2024
Which NZX firms lost or gained NZ Super Fund investment
Markets

Which NZX firms lost or gained NZ Super Fund investment

The fund is an active investor in NZ. Here are the firms it likes, and those it dumped.